You are here: Industry Insights > AI

News List

Standigm Secures $10 M From Pavilion Capital to Accelerate Its Global Competitiveness firstwordpharma
July 07, 2021
Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, announced today that they have secured a $10 million investment from Pavilion Capital, a Singapore-based investment institution.
Exscientia signs $1.2bn AI drug discovery deal with BMS pharmaceutical-technology
May 21, 2021
Bristol-Myers Squibb (BMS) and Exscientia have signed a partnership agreement to leverage artificial intelligence (AI) for the discovery of small molecule drug candidates in various therapeutic areas, including oncology and immunology.
Alzheimer’s drug designed using Exscientia’s AI technology enters clinic pharmatimes
May 17, 2021
An Alzheimer’s disease drug candidate designed using Exscientia’s artificial intelligence (AI) technology has entered Phase I clinical testing, the company announced May 13.
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing Presagen
May 17, 2021
Presagen has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF.
First AI designed Alzheimer’s drug to enter clinical trials europeanpharmaceuticalreview
May 14, 2021
The trial of DSP-0038, an Alzheimer’s disease psychosis drug designed using artificial intelligence, will assess its ability to improve the behavioural and psychological symptoms of dementia.
Abbott’s AI-powered coronary imaging platform deployed in the UK pharmatimes
May 14, 2021
Abbott UK’s artificial intelligence- (AI) powered coronary imaging platform has been offered to the first heart attack patients in the country at the Royal Free Hospital in London.
Artificial intelligence model predicts which key of the immune system opens the locks of coronavirus worldpharmanews
April 26, 2021
The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them.
US approval for first AI device to help detect colon cancer pharmatimes
April 13, 2021
The US Food and Drug Administration (FDA) has authorised a new medical device that uses artificial intelligence (AI) based on machine learning to help clinicians detect potentials signs of colon cancer.
EU approval for new AI technology that can predict heart attacks pharmatimes
March 31, 2021
New artificial intelligence (AI) technology that can identify if people are at high risk of having a fatal heart attack before it occurs has been approved in the EU.
University team uses AI to decode asbestos-linked cancer pharmaceutical-technology
March 29, 2021
Researchers at the University of Leicester have used artificial intelligence (AI) to gain new insights into mesothelioma, a cancer caused by breathing asbestos particles that typically occurs in the linings of the lungs or abdomen.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page